July 26, 2014 / 11:49 AM / in 3 years

Merck aims to hike revenues in China to 1 billion euro by 2018

FRANKFURT (Reuters) - Merck (MRCG.DE) will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros ($1.3 billion) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.

A branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt March 7, 2012. REUTERS/Alex Domanski

Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said.

($1 = 0.7447 Euros)

Reporting by Edward Taylor; Editing by Ruth Pitchford

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below